Maria Nikoloudi
Papers
1
Total Citations
2
H-Index
1
About
Dr. Maria Nikoloudi is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic ablative radiotherapy (SABR) for early-stage lung cancer. Her most cited work, a 2024 interim analysis on robotic SABR, addresses a critical gap in oncology: providing a non-invasive, highly effective treatment alternative for patients who are medically inoperable or who decline surgery. This study demonstrates her major contribution to refining radiotherapy protocols, showing that precise, robotic delivery of high-dose radiation can achieve excellent tumor control while minimizing damage to healthy lung tissue. With her research accumulating citations that underscore its clinical relevance, Dr. Nikoloudi is helping to shift the standard of care for early-stage lung cancer toward less invasive options. Her work not only improves survival outcomes but also enhances quality of life for vulnerable patients. As a researcher at the forefront of technological innovation in radiotherapy, Dr. Nikoloudi is shaping a future where more patients can access curative treatment without the risks of major surgery.
Research Focus
Key Achievements
Top Papers
- 1